For the Inventor, By the Inventor

Enter assignee name

Abingdon, United Kingdom

Syntaxin Limited

USPTO Granted Patents = 36

CIPO Patents = 2

EPO Patents = 5

Forward Citations = 385

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Keith Foster (30 out of 49 patents)

John Andrew Chaddock (27 out of 41 patents)

Philip Marks (18 out of 26 patents)

4. Patrick Stancombe (17 out of 20 patents)

5. Lance Steward (13 out of 102 patents)

6. Joseph Francis (13 out of 51 patents)

7. Kei Roger Aoki (12 out of 126 patents)

8. Clifford Charles Shone (10 out of 27 patents)

9. Conrad Padraig Quinn (9 out of 24 patents)

10. Charles Penn (7 out of 9 patents)

11. Jonathan Wayne (6 out of 8 patents)

12. John Mark Sutton (4 out of 8 patents)

13. J Mark Sutton (4 out of 10 patents)

14. Lyndsey Durose (4 out of 4 patents)

15. Michael John Duggan (4 out of 8 patents)

36 patents: Sort by Forward Citations

1. 9139635 - Non-cytotoxic protein conjugates (2015-09-22),

2. 9115350 - Carrier for targeting nerve cells (2015-08-25),

3. 9072736 - Treatment of pain (2015-07-07),

4. 9012195 - Non-cytotoxic protein conjugates (2015-04-21),

5. 8956847 - Fusion proteins (2015-02-17),

6. 8940870 - Fusion proteins (2015-01-27),

7. 8852603 - Inhibition of secretion from non-neuronal cells (2014-10-07),

8. 8796216 - Suppression of neuroendocrine diseases (2014-08-05),

9. 8790897 - Treatment of mucus hypersecretion (2014-07-29),

10. 8778634 - Non-cytotoxic protein conjugates (2014-07-15),

11. 8614069 - Non-cytotoxic fusion proteins comprising EGF muteins (2013-12-24),

12. 8603779 - Non-cytotoxic protein conjugates (2013-12-10),

13. 8512984 - Non-cytotoxic protein conjugates (2013-08-20),

14. 8481040 - Carrier for targeting nerve cells (2013-07-09),

15. 8454976 - Recombinant toxin fragments (2013-06-04),

Syntaxin Limited is a leading biotechnology company specializing in the research and development of innovative medical solutions. With a focus on neurology and genetic disorders, Syntaxin aims to transform the lives of patients through groundbreaking therapeutic approaches. Through extensive scientific expertise and cutting-edge technology, Syntaxin continues to push the boundaries of medical innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

36 Patents

#6 in Abingdon

#484 in United Kingdom

#18,179 in the World

Abingdon, United Kingdom

Syntaxin Limited

Forward Citations = 385

26 inventors:

Keith Foster (30 out of 49 patents)

John Andrew Chaddock (27 out of 41 patents)

Philip Marks (18 out of 26 patents)

4. Patrick Stancombe (17 out of 20 patents)

5. Lance Steward (13 out of 102 patents)

Please report any incorrect information to support@idiyas.com

Loading…